Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Innovate Biopharmaceuticals (INNT) Competitors

Innovate Biopharmaceuticals logo

INNT vs. SCPS, EVLO, CMRA, ARDS, STAB, AMPE, EFTR, HSTO, MTEM, and ONCSQ

Should you be buying Innovate Biopharmaceuticals stock or one of its competitors? The main competitors of Innovate Biopharmaceuticals include Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), Histogen (HSTO), Molecular Templates (MTEM), and OncoSec Medical (ONCSQ). These companies are all part of the "medical" sector.

Innovate Biopharmaceuticals vs. Its Competitors

Scopus BioPharma (NASDAQ:SCPS) and Innovate Biopharmaceuticals (NASDAQ:INNT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Innovate Biopharmaceuticals N/A N/A -234.42%

Scopus BioPharma has a beta of -0.19, indicating that its stock price is 119% less volatile than the S&P 500. Comparatively, Innovate Biopharmaceuticals has a beta of -0.39, indicating that its stock price is 139% less volatile than the S&P 500.

In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Innovate Biopharmaceuticals'average media sentiment score.

Company Overall Sentiment
Scopus BioPharma Neutral
Innovate Biopharmaceuticals Neutral

5.9% of Innovate Biopharmaceuticals shares are owned by institutional investors. 5.1% of Scopus BioPharma shares are owned by company insiders. Comparatively, 7.9% of Innovate Biopharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
Innovate BiopharmaceuticalsN/AN/A-$27.05MN/AN/A

Summary

Scopus BioPharma beats Innovate Biopharmaceuticals on 3 of the 5 factors compared between the two stocks.

Get Innovate Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INNT vs. The Competition

MetricInnovate BiopharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$8K$838.55M$5.55B$9.11B
Dividend YieldN/A4.84%5.07%4.01%
P/E Ratio-1.791.1628.2120.26
Price / SalesN/A241.37432.0099.74
Price / CashN/A17.6937.1257.67
Price / BookN/A6.588.045.49
Net Income-$27.05M-$23.83M$3.19B$250.45M

Innovate Biopharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INNT
Innovate Biopharmaceuticals
N/AN/AN/AN/A$8KN/A-1.798
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.3%$6K$1.00M0.002
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/AN/A$5KN/A0.0030News Coverage
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020
AMPE
Ampio Pharmaceuticals
N/A$0.00
-32.5%
N/A-99.9%$3KN/A0.0020Gap Down
EFTR
eFFECTOR Therapeutics
0.0794 of 5 stars
$0.00
-33.3%
N/A-99.4%$1KN/A0.0010Gap Down
HSTO
Histogen
N/A$0.00
flat
N/AN/A$1K$19K0.0020Gap Down
MTEM
Molecular Templates
N/AN/AN/AN/A$1K$23.48M0.00260
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1KN/A0.0040

Related Companies and Tools


This page (NASDAQ:INNT) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners